Search

everythinglearnresearchcommunity

for

Search:↓

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Using neurohormones to control keratin can lead to new skin disease treatments.

Neurohormones help control skin health and could treat skin disorders.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Activating δ-opioid receptors can help hair grow.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.